Edition:
United Kingdom

People: ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

68.54USD
16 Aug 2019
Change (% chg)

$1.45 (+2.16%)
Prev Close
$67.09
Open
$66.89
Day's High
$68.56
Day's Low
$66.89
Volume
71,671
Avg. Vol
50,049
52-wk High
$86.67
52-wk Low
$39.83

Schrepfer, Robert 

Mr. Robert W. Schrepfer is Senior Vice President of New Business Development and Specialty Sales of the company. he served as Vice President - New Business Development and Contract Manufacturing of the Company. Mr. Schrepfer had served as the Company’s Vice President of New Business Development and Contract Manufacturing and was promoted to Senior Vice President of New Business Development and Specialty Sales in May 2016. From 2005 to 2013, Mr. Schrepfer served as Assistant Portfolio Manager at Healthcare Value Capital, LLC, an SEC-registered healthcare investment firm. Mr. Schrepfer co-managed the firm’s private equity portfolio and oversaw investments in healthcare services, devices and specialty pharmaceuticals. In addition, he was principal and founder of National Healthcare Analysis Group, LLC and served as Chief Financial Officer of National Healthcare Analysis Partners 1, LP, a partnership that seeks to identify and pursue healthcare fraud.

Basic Compensation

Total Annual Compensation, USD 671,459
Restricted Stock Award, USD 456,480
Long-Term Incentive Plans, USD --
All Other, USD 316,217
Fiscal Year Total, USD 1,444,160

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Brown

273,573

Arthur Przybyl

4,197,930

Stephen Carey

1,438,750

Robert Schrepfer

1,444,160

James Marken

1,009,590

Thomas Haughey

252,569
As Of  31 Dec 2018